Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute hepatitis C virus infection.

Raymond T Chung1

  • 1Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA 02114-2696, USA. rtchung@partners.org

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|November 3, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatitis B and Hepatitis C Virus Infection Promote Liver Fibrogenesis through a TGF-β1-Induced OCT4/Nanog Pathway.

Journal of immunology (Baltimore, Md. : 1950)·2022
Same author

A Prospective Cohort Study of Novel Markers of Hepatitis B Virus Replication in Human Immunodeficiency Virus Coinfection.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2022
Same author

Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development.

Gastroenterology·2021
Same author

Reply.

Hepatology (Baltimore, Md.)·2021
Same author

Reply.

Hepatology (Baltimore, Md.)·2021
Same author

Incidence and prediction of HBsAg seroclearance in a prospective multi-ethnic HBeAg-negative chronic hepatitis B cohort.

Hepatology (Baltimore, Md.)·2021

Acute hepatitis C virus (HCV) infection is often asymptomatic but treatable. Early interferon-based therapy and understanding immune responses are key to better outcomes and potential vaccines.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Acute hepatitis C virus (HCV) infection is common in substance users but often asymptomatic and underrecognized.
  • Recent studies of acute HCV infection cohorts have yielded significant insights.

Purpose of the Study:

  • To summarize recent findings on acute HCV infection.
  • To explore factors influencing spontaneous clearance and treatment outcomes.
  • To discuss potential vaccine strategies and future research directions.

Main Methods:

  • Analysis of cohort studies focusing on acute HCV infection.
  • Investigation of symptomatic vs. asymptomatic infection outcomes.
  • Examination of host immune responses (innate and adaptive) and genetic polymorphisms.

Related Experiment Videos

  • Review of data from injection drug users with repeated HCV exposures.
  • Evaluation of antiviral therapy efficacy in acute HCV infection.

    • Main Results:

    • Symptomatic acute HCV infection and strong adaptive immune responses correlate with higher spontaneous clearance rates.
    • Innate immunity gene polymorphisms impact HCV infection outcomes.
    • Repeated HCV exposures in injection drug users suggest partially protective immunity, supporting vaccine feasibility.
    • Interferon-based antiviral therapy for acute HCV infection yields superior sustained virological response rates compared to chronic infection.

    Conclusions:

    • Acute HCV infection dynamics are influenced by host immunity and viral factors.
    • Early antiviral treatment shows promise for improved outcomes.
    • Further research is needed for better diagnostic assays, predictive factor identification, and optimized therapeutic regimens.